Efficacy Maxinom® And Maxitrol® in Reducing The Signs And Symptoms Of Acute Bacterial Conjunctivitis

Inclusion Criteria: * Patients who agree with all study procedures and sign, by his own free will, IC; * Adult patients, regardless of gender, ethnicity or social status, with good mental health; * Patients who present at screening visit, picture of acute bacterial conjunctivitis diagnosed clinically. Exclusion Criteria: * Patients with clinical diagnosis or suspicion of conjunctivitis due to any process that is not due to bacterial infection, such as infections by fungi, protozoa, viruses and allergic conjunctivitis; * Patients with known hypersensitivity to any component of the formulas of the study drugs; * Patients with a history or clinical diagnosis of other lesions that may affect the outcome, such as glaucoma, corneal ulcer or scars; * Concomitant use of ocular medication other than the study; * Pregnant or lactating women; * Being or having been treated for any type of conjunctivitis within 15 days and have finished treatment or less than 07 days